Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan · Delayed Price · Currency is TWD 74.00
+0.60 (0.82%)
Sep 8, 2026, 1:20 PM CST
TPEX:7427 Market Cap
TPEX:7427 has a market cap or net worth of 3.88 billion as of September 4, 2026. Its market cap has increased by 182.58% in one year.
Market Cap
3.88B
Enterprise Value
3.19B
Revenue
6.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
74.00
ChartMarket Cap Chart
Since July 8, 2021, TPEX:7427's market cap has increased from 1.48B to 3.88B, an increase of 162.67%. That is a compound annual growth rate of 20.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 3.15B | 129.38% |
| Dec 31, 2025 | 1.37B | -7.37% |
| Dec 31, 2024 | 1.48B | -42.09% |
| Dec 29, 2023 | 2.56B | 40.55% |
| Dec 30, 2022 | 1.82B | 94.83% |
| Dec 30, 2021 | 935.73M | -36.72% |
| Jul 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sinew Pharma | 3.69B |
| BioGend Therapeutics | 3.53B |
| SYN-TECH Chem. & Pharm. | 3.35B |
| BRIM Biotechnology | 3.35B |
| OBI Pharma | 3.28B |
| Apex Biotechnology | 3.23B |
| Shine-On BioMedical | 3.20B |
| Sagittarius Life Science | 3.12B |